Literature DB >> 20835812

[Necrotizing fasciitis caused by Acinetobacter baumannii : A case report].

J A Wagner1, P Nenoff, W Handrick, R Renner, J Simon, R Treudler.   

Abstract

A 42-year-old man developed necrotizing fasciitis on the right leg. A multidrug-resistant Acinetobacter baumannii was cultivated from the deep wound. Following therapy with imipenem and tobramycin as well as extensive debridement, the lesions improved slowly. A. baumannii is today an important cause of nosocomial infections, especially in intensive care units.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20835812     DOI： 10.1007/s00105-010-1962-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  9 in total

Review 1.  Acinetobacter species as nosocomial pathogens.

Authors:  D H Forster; F D Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

Review 2.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 3.  Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species.

Authors:  James J Rahal
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

4.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

5.  Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

Authors:  Juliana M Coelho; Jane F Turton; Mary E Kaufmann; Judith Glover; Neil Woodford; Marina Warner; Marie-France Palepou; Rachel Pike; Tyrone L Pitt; Bharat C Patel; David M Livermore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 6.  Drug treatment for multidrug-resistant Acinetobacter baumannii infections.

Authors:  Matteo Bassetti; Elda Righi; Silvano Esposito; Nicola Petrosillo; Laura Nicolini
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

Review 7.  Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

Authors:  Drosos E Karageorgopoulos; Matthew E Falagas
Journal:  Lancet Infect Dis       Date:  2008-12       Impact factor: 25.071

8.  Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-11-19       Impact factor: 17.586

9.  Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections.

Authors:  Ronald Gounden; Colleen Bamford; Richard van Zyl-Smit; Karen Cohen; Gary Maartens
Journal:  BMC Infect Dis       Date:  2009-03-09       Impact factor: 3.090
  9 in total
  2 in total

1.  Two Acinetobacter baumannii Isolates Obtained From a Fatal Necrotizing Fasciitis Infection Display Distinct Genomic and Phenotypic Characteristics in Comparison to Type Strains.

Authors:  Jennifer T Grier; Brock A Arivett; Maria S Ramírez; Renee J Chosed; Jessica A Bigner; Emily J Ohneck; Maeva L Metz; Cecily R Wood; Sergio Arce; Andrea Tartaro; Ryan F Relich; Luis A Actis; Steven E Fiester
Journal:  Front Cell Infect Microbiol       Date:  2021-04-12       Impact factor: 5.293

Review 2.  Spatio-Temporal Distribution of Acinetobacter baumannii in Germany-A Comprehensive Systematic Review of Studies on Resistance Development in Humans (2000-2018).

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  Microorganisms       Date:  2020-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.